196 related articles for article (PubMed ID: 3030546)
1. In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.
Lotze MT; Custer MC; Sharrow SO; Rubin LA; Nelson DL; Rosenberg SA
Cancer Res; 1987 Apr; 47(8):2188-95. PubMed ID: 3030546
[TBL] [Abstract][Full Text] [Related]
2. IL 2 receptor induction on human T lymphocytes: role for IL 2 and monocytes.
Wakasugi H; Bertoglio J; Tursz T; Fradelizi D
J Immunol; 1985 Jul; 135(1):321-7. PubMed ID: 2987347
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
[TBL] [Abstract][Full Text] [Related]
5. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
Bich-Thuy LT; Dukovich M; Peffer NJ; Fauci AS; Kehrl JH; Greene WC
J Immunol; 1987 Sep; 139(5):1550-6. PubMed ID: 3040856
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
[TBL] [Abstract][Full Text] [Related]
7. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
9. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
Palacios R
J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
[TBL] [Abstract][Full Text] [Related]
10. IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.
Taylor DS; Kern JA; Nowell PC
J Immunol; 1986 Mar; 136(5):1620-4. PubMed ID: 3005396
[TBL] [Abstract][Full Text] [Related]
11. Expression and the functional role of a p70/75 interleukin 2-binding molecule in human B cell.
Saiki O; Tanaka T; Doi S; Kishimoto S
J Immunol; 1988 Feb; 140(3):853-8. PubMed ID: 2828472
[TBL] [Abstract][Full Text] [Related]
12. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
Ceuppens JL; Baroja ML
J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
[TBL] [Abstract][Full Text] [Related]
14. Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2.
Ellis TM; Creekmore SP; McMannis JD; Braun DP; Harris JA; Fisher RI
Cancer Res; 1988 Nov; 48(22):6597-602. PubMed ID: 2902918
[TBL] [Abstract][Full Text] [Related]
15. Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.
Miyawaki T; Ohzeki S; Ikuta N; Seki H; Taga K; Taniguchi N
J Immunol; 1984 Dec; 133(6):2996-3000. PubMed ID: 6092463
[TBL] [Abstract][Full Text] [Related]
16. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
Waldmann TA; Tsudo M
Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696
[TBL] [Abstract][Full Text] [Related]
17. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.
Depper JM; Leonard WJ; Krönke M; Noguchi PD; Cunningham RE; Waldmann TA; Greene WC
J Immunol; 1984 Dec; 133(6):3054-61. PubMed ID: 6092466
[TBL] [Abstract][Full Text] [Related]
18. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
[TBL] [Abstract][Full Text] [Related]
19. Analysis of human prenatal and postnatal thymocytes with the anti-Tac monoclonal antibody and recombinant interleukin-2.
Plum J; de Smedt M
Thymus; 1987; 9(3):149-58. PubMed ID: 3109082
[TBL] [Abstract][Full Text] [Related]
20. In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.
McMannis JD; Fisher RI; Creekmore SP; Braun DP; Harris JE; Ellis TM
J Immunol; 1988 Feb; 140(4):1335-40. PubMed ID: 3257776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
